Physician profile
Amber Erben
NPI 1760894695
$1,209.23
in general payments reported to CMS, 2019-2025
23 companies · $438 in 2025
The $438 reported for 2025 was more than what 75% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.00 · 2023: $471 · 2024: $218 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $182.88 | 2023-2025 | Xeomin, Inbrija |
| Ge Healthcare | $113.99 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $92.45 | 2023-2024 | Ultomiris |
| Lundbeck LLC | $79.42 | 2023-2025 | Vyepti, Rexulti |
| Abbvie INC. | $77.36 | 2023-2024 | |
| Sk Life Science, INC. | $76.86 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $64.38 | 2023-2024 | Austedo Xr, Ajovy |
| Genentech USA, INC. | $60.43 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Corium, LLC | $56.69 | 2022-2023 | Adlarity |
| Argenx US, INC. | $49.39 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Harmony Biosciences LLC | $48.97 | 2025 | |
| Ucb, INC. | $45.22 | 2023 | Briviact |
| Banner Life Sciences, LLC | $44.75 | 2023 | |
| Amgen INC. | $34.54 | 2024 | Uplizna |
| E.R. Squibb & Sons, L.L.C. | $30.28 | 2023 | Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.46 | 2025 | |
| Neurocrine Biosciences, INC. | $21.56 | 2024 | Ingrezza |
| Horizon Therapeutics Plc | $21.13 | 2022 | |
| Celgene Corporation | $17.49 | 2025 | Zeposia |
| Mallinckrodt Hospital Products INC. | $17.23 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.06 | 2023 | Onpattro |
| Lilly USA, LLC | $16.64 | 2025 | Kisunla |
| Medtronic, INC. | $14.05 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Erben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.